MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Cytek Biosciences Inc

Closed

SectorHealthcare

4.55 -1.09

Overview

Share price change

24h

Current

Min

4.53

Max

4.65

Key metrics

By Trading Economics

Income

-39M

-44M

Sales

9.8M

62M

Profit margin

-70.929

Employees

702

EBITDA

4M

-263K

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+35.57% upside

Dividends

By Dow Jones

Next Earnings

7 May 2026

Market Stats

By TradingEconomics

Market Cap

29M

590M

Previous open

5.64

Previous close

4.55

News Sentiment

By Acuity

50%

50%

159 / 348 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Cytek Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

20 Apr 2026, 23:49 UTC

Major News Events

New Zealand 1Q Inflation Higher Than Expected

20 Apr 2026, 23:10 UTC

Hot Stocks

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 Apr 2026, 22:53 UTC

Major Market Movers

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 Apr 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 Apr 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 Apr 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 Apr 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 Apr 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 Apr 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 Apr 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 Apr 2026, 22:31 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 Apr 2026, 22:26 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 Apr 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 Apr 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Aims for Acquisition to Be Completed by End-2026

20 Apr 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 Apr 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Acquisition Would Be for A$175 Million

20 Apr 2026, 22:24 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 Apr 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 Apr 2026, 22:01 UTC

Acquisitions, Mergers, Takeovers

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 Apr 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 Apr 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 Apr 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 Apr 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 Apr 2026, 21:13 UTC

Earnings

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 Apr 2026, 21:10 UTC

Earnings

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 Apr 2026, 21:09 UTC

Earnings

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 Apr 2026, 21:08 UTC

Earnings

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 Apr 2026, 21:07 UTC

Earnings

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 Apr 2026, 21:05 UTC

Earnings

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 Apr 2026, 21:05 UTC

Earnings

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Peer Comparison

Price change

Cytek Biosciences Inc Forecast

Price Target

By TipRanks

35.57% upside

12 Months Forecast

Average 6.25 USD  35.57%

High 7.5 USD

Low 5 USD

Based on 2 Wall Street analysts offering 12 month price targets forCytek Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

3.7 / 3.8Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

159 / 348 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat